FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:2089-2092 June 27, 2002 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Pascual, M. PubMed Citation

To the Editor: Like most reviews of strategies to improve outcomes in recipients of renal transplants, the recent article by Pascual et al. (Feb. 21 issue)¹ focused on immunologic issues and immunosuppression. It is becoming clear, however, that the most common cause of graft loss is death (due to cardiovascular disease in 30 to 50 percent of cases) and that most chronic graft loss is nonimmunologic.² Pascual et al., in fact, concede these points. It stands to reason that aggressive treatment of nonimmunologic causes of graft failure and cardiovascular disease might have a larger effect in renal-transplant recipients than any . . . [Full Text of this Article]

This article has been cited by other articles:

• Boehler, A., Estenne, M. (2003). Post-transplant bronchiolitis obliterans. Eur Respir J 22: 1007-1018 [Abstract] [Full Text]